Cardiovascular effects of estrogen: Implications of the discovery of the estrogen receptor subtype β

Current Opinion in Nephrology and Hypertension

Volumn 7, Issue 1, 1998, Pages 83-89

  Foegh, Marie L ^a   Ramwell, Peter W ^a,b  

^a GEORGETOWN UNIVERSITY MEDICAL CENTER   (United States)

^b GEORGETOWN UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ESTROGEN; ESTROGEN RECEPTOR; RECEPTOR SUBTYPE;

AMINO ACID SEQUENCE; ANGIOGENESIS; BLOOD PRESSURE REGULATION; ESTROGEN ACTIVITY; GENE EXPRESSION REGULATION; HEART HEMODYNAMICS; HEART PROTECTION; HORMONAL REGULATION; HORMONE RECEPTOR INTERACTION; HUMAN; NONHUMAN; PRIORITY JOURNAL; PROTEIN DETERMINATION; RECEPTOR DENSITY; RECEPTOR UPREGULATION; REVIEW; SEQUENCE HOMOLOGY; TRANSCRIPTION REGULATION; TRANSGENIC MOUSE;

ANIMALS; CARDIOVASCULAR PHYSIOLOGY; ESTROGENS; HEMODYNAMIC PROCESSES; HUMANS; RECEPTORS, ESTROGEN;

EID: 0031984266     PISSN: 10624821     EISSN: None     Source Type: Journal    
DOI: 10.1097/00041552-199801000-00014     Document Type: Review

References (54)

1. Farhat MY, Lavigne MC, Ramwell PW. The vascular protective effects of estrogen. FASEB J 1996; 10:615-624.
2. Farhat MY, Abi-Younes S, Ramwell PW. Non genomic effects of estrogen on the vessel wall. Biochem Pharmacol 1996; 51:571-576.
3. 1 sites. Science 1997; 277:1508-1510. A highly significant paper.
4. Kuiper GGJM, Enmark E, Pelto-Huikko M, Nilsson S, Gustafsson J-A. Cloning of a novel estrogen receptor expressed in rat prostate and ovary. Proc Natl Acad Sci USA 1996; 93:5925-5930. This is a 'discovery' paper that should be carefully read.
5. Mosselman S, Polman J, Dijkema R. ERβ: identification and characterization of a novel human estrogen receptor. FEBS Lett 1996; 392:49-53. This is a 'discovery' paper that should be carefully read.
6. Pettersson K, Grandien K, Kuiper GGJM, Gustafsson J-A. Mouse estro gen receptor β forms estrogen response element-binding heterodimers with estrogen receptor α. Mol Endocrinol 1937; 11:1486-1496. This is a 'discovery' paper that should be carefully read.
7. Kuiper GGJM, Carlsson B, Grandien K, Enmark E, Haggblad J, Nilsson S, et al. Comparison of the ligand binding specificity and transcript tissue distribution of estrogen receptors α and β. Endocrinology 1997; 138:863-870. This is a 'discovery' paper that should be carefully read.
8. Shughrue PJ, Komm B, Merchenthaler I. The distribution of estrogen receptor-β mRNA in the rat hypothalamus. Steroids 1996; 61:678-681 This is a 'discovery' paper that should be carefully read.
9. Iafratti D, Karas RH, Aronovitz M, Kim S, Sullivan TR, Lubahn DB, et al. Estrogen inhibits the vascular injury response in estrogen receptor α-deficient mice. Nature Med 1997; 3:545-548. This is a 'discovery' paper that should be carefully read.
10. Dotzlaw H, Leygue E, Watson PH, Murphy LC. Expression of estrogen receptor-beta in human breast tumors. J Clin Endocrinol Metab 1996; 82:2371-2374. This is a 'discovery' paper that should be carefully read.
11. Tremblay GB, Tremblay A, Copeland NG, Gilbert DJ, Jenkins NA, Labrie F, et al. Cloning, chromosomal localization and functional analysis of the murine estrogen receptor β. Mol Endocrinol 1997; 11:353-365. This is a 'discovery' paper that should be carefully read.
12. Rochefort H. Oestrogen- and anti-oestrogen-regulated genes in human breast cancer. In: Non-reproductive actions of sex steroids. Ciba Foundation Symposium 191. Wiley & Sons, Chichester, England; 1995. pp. 254-269.
13. Feldmer M, Kalling M, Takahshi S, Mullins JJ, Ganten D. Glucocorticoid-and estrogen-responsive elements in the 5′-flanking region of the rat angiotensinogen gene. J Hypertens 1991; 9:1005-1012.
14. Adesanya OO, Zhou J, Bondy C. Sex steroid regulation of insulin-like growth factor system gene expression and proliferation in primate myometrium. J Clin Endocrinol Metab 1996; 81:1967-1974.
15. Vargas R, Wroblewska B, Rego A, Hatch J, Ramwell PW. Oestradiol inhibits smooth muscle cell proliferation of pig coronary artery. Br J Pharmacol 1993; 109:612-617.
16. Lou H, Zhao Y, Delafontaine P, Kodoma T, Katz N, Ramwell PW, et al. Estrogen effects on Insulin-like growth factor-I (IGF-I)-induced cell proliferation and IGF-I expression in native and allograft vessels. Circulation 1997; 96:927-933.
17. Vargas R, Hewes B, Rego A, Farhat MY, Suarez R, Ramwell PW. Estradiol effect on rate of proliferation of rat carotid segments: effect of gender and tamoxifen. J Cardiovasc Pharmacol 1996; 27:495-499.
18. Bei M, Lavigne MC, Foegh ML, Ramwell PW, Clarke R. Specific binding of estradiol to rat coronary artery smooth muscle cells. J Steroid Biochem Molec Biol 1996; 58:83-88. A paper of interest.
19. Neville RF, Sidawy AN, Foegh ML. The molecular biology of vein graft atherosclerosis and myointimal hyperplasia. Curr Opin Cardiol 1992; 7:930-938
20. Foegh ML, Zhao Y, Farhat M, Ramwell PW. Oestradiol inhibition of vascular myointimal proliferation following immune, chemical and mechanical injury. In: Non-reproductive actions of sex steroids. Proceedings of the Ciba Foundation Symposium 191. Wiley & Sons, Chichester, England; 1995. pp. 139-149.
21. Foegh ML, Virmani R. The molecular biology of intimai proliferation. Curr Opin Cardiol 1993; 8:938-950.
22. Foegh ML, Asotra S, Howell MH, Ramwell PW. Estradiol inhibition of arterial neointimal hyperplasia after balloon injury. J Vasc Surg 1994; 19:722-726. A paper of interest.
23. Chen SJ, Li H, Durand J, Oparil S, Chen YF. Estrogen reduces myointimal proliferation after balloon injury of rat carotid artery. Circulation 1996; 93:577-584.
24. Foegh M, Rego A, Lou H, Katz N, Ramwell PW. Gender effects on graft myointimal hyperplasia. Transplant Proc 1995; 27:2070-2073.
25. Foegh ML. Estradiol and myointimal proliferation. In: Proceedings of the Schering Foundation Symposium: Sex steroids and the cardiovascular system. Ramwell P, Rubanyi G, Schilliager P (editors). Berlin: Springer-Verlag; 1992. pp. 129-137.
26. Krasinski K, Spyridopoulos I, Asahara T, van der Zee R, Isner JM, Losordo DW. Estradiol accelerates functional endothelial recovery after arterial injury. Circulation 1997; 95:1768-1772.
27. Foegh ML, Khirabadi BS, Nakanishi T, Vargas R, Ramwell PW. Estradiol protects against experimental cardiac transplant atherosclerosis. Transplant Proc 1987; 19:90-93. A key paper for this field.
28. Cheng LP, Kuwahara M, Jacobsson J, Foegh ML. Inhibition of myointimal hyperplasia and macrophage infiltration by estradiol in aorta allogratts. Transplantation 1991; 52:967-972.
29. Ewel CH, Foegh ML. Chronic graft rejection: accelerated transplant arteriosclerosis. Immunol Rev 1993; 134:21-31.
30. Motomura N, Lou H, Hong M, Tsutsumi Y, Mayumi T, Foegh ML. Local administration of estrogen inhibits transplant arteriosclerosis in rat aorta accelerated by topical exposure to IGF-I. Transplant Proc 1997; 29:1118-1120.
31. Hosenpud JD, Bennett LE, Keck BM, Fiol B, Novick RJ. The registry of the International Society for Heart and Lung Transplantation: fourteenth official report - 1997. J Heart Lung Transplant 1997; 16:691-712.
32. Candinas D, Gunson BK, Nightingale P, McMaster P, Neuberger JM. Sex mismatch as a risk factor for chronic rejection of liver allografts. Lancet 1995, 346:1117-1121.
33. Lou H, Kodama T, Maurice P, Wang YN, Katz NM, Foegh ML. Inhibition of transplant coronary arteriosclerosis in rabbits by chronic estradiol treatment is associated with abolishing MHC class II antigen expression. Circulation 1996; 94:3355-3361. This paper highlights an important discovery.
34. Saito S, Motomura N, Lou, H, Ramwell PW, Foegh ML. Specific effects of estrogen on growth factor and major histocompatibility (MHC) class II expression in rat aorta allograft. J Thorac Cardiovasc Surg 1997; 14:803-810. This paper opens up a new area.
35. Lou H, Kodama T, Wang YN, Katz NM, Ramwell PW, Foegh ML. Major histocompatibility complex (MHC) class II antigen expression is suppressed by estradiol in cardiac allografts. Transplant Proc 1997; 29:2620-2821.
36. Johns A, Frea AD, Fraser W, Korach KS, Rubanyi GM. Disruption of estrogen receptor gene prevents 17β estradiol-induced angiogenesis in transgenic mice. Endocrinology 1996; 137:4511-4513.
37. Smith EP, Boyd J, Frank GR, Takahasi H, Cohen RM, Specker B, et al. Estrogen resistance caused by a mutation in the estrogen-receptor gene in a man. N Engl J Med 1994; 331:1056-1061.
38. Sudhir K, Chou TM, Messina LM, Hutchison SJ, Korach KS, Chatterjee K, et al. Endothelial dysfunction in a man with disruptive mutation in oestrogen-receptor gene. Lancet 1997; 349:1146-1147.
39. Williams JK, Kim YD, Adams MR, Chen M-F, Myers AK, Ramwell PW. Effects of estrogen on cardiovascular responses of premenopausal monkeys. J Pharmacol Exp Ther 1994; 271:671-676.
40. Ghigo D, Alessio P, Foco A, Bussolino F, Costamagna C, Heller R, et al. Nitric oxide synthesis is impaired in glutathione-depleted human umbilical vein endothelial cells. Am J Physiol 1993; 265:C728-C732.
41. Arnal JF, Clamens S, Pechet C, Negre-Salvayre A, Allera C, Girolami J-P, et al. Ethinylestradiol does not enhance the expression of nitric oxide synthase in bovine endothelial cells but increases the release of bioactive nitric oxide by inhibiting superoxide anion production. Proc Natl Acad Sci USA 1996; 93:4108-4113.
42. Imthum B, Roselli M, Jaeger AW, Keller PJ, Dubey RK. Differential effects of hormone replacement therapy on endogenous nitric oxide (nitrite nitrate) levels in postmenopausal women substituted with 17β-estradiol valerate and cyproterone acetate or medroxyprogesterone acetate. J Clin Endocrinol Metab 1997; 82:388-394.
43. Farhat MY, Abi-Younes S, Dingaan B, Vargas R, Ramwell PW. Estradiol increases cyclic adenosine monophosphate in rat pulmonary vascular smooth muscle cells by a nongenomic mechanism. J Pharmacol Exp Ther 1996; 276:652-657.
44. Williams JK, Adams MR, Klopfenstein HS. Estrogen modulates responses of atherosclerotic coronary arteries. Circulation 1990; 81:1680-1687.
45. Guette V, Cannon RO. Cardiovascular effects of estrogen and lipid-lower ing therapies in postmenopausal women. Circulation 1996; 93:1928-1937. A paper of interest.
46. Nalssen T, Berglund L, Ulmsten U. Bone loss in elderly women prevented by ultralow doses of parenteral 17β estradiol. Am J Obstet Gynecol 1997; 177:115-119
47. Crofton JT, Share L. Gonadal hormones modulate deoxycorticosterone-salt hypertension in male and female rats. Hypertension 1997; 29:494-499.
48. Bunag RD. Exaggeration of experimental hypertension in rats by contraceptive steroids (Enovid). Endocrinology 1976; 98:1315-1320.
49. Thomas G, Ito K, Zikic E, Bhatti T, Han C, Ramwell PW. Specific inhibition of the contraction of the rat aorta by estradiol 17β. J Pharmacol Exp Ther 1995; 273:1544-1556.
50. + and U-46619. J Cardiovasc Pharmacol 1995; 25:200-206.
51. Hatano T, Ogawa K, Kanda K, Seo H, Matsui N. Effect of ovarian steroids on cyclic adenosine 3′:5′-monophosphate production stimulated by arginine vasopressin in rat renal monolayer cultured cells. Endocrinol Jap 1988; 35:267-274.
52. Wang Y-X, Edwards RM, Nambi P, Stack EJ, Pullen M, Share L, et al. Sex difference in the antidiuretic activity of vasopressin in the rat. Am J Physiol 1993; 265:R1284-R1290.
53. Aronica SM, Kraus WL, Katzenellenbogen BS. Estrogen action via the cAMP signaling pathway: Stimulation of adenylate cyclase and cAMP-regulated gene transcription. Cell Biol 1994; 91:8517-8521.
54. Schunkert H, Danser AHJ, Hense H-W, Derkx FHM, Kurzinger S, Riegger GAJ. Effects of estrogen replacement therapy on the renin angiotensin system in postmenopausal women. Circulation 1997; 95:39-45.